Secretory Phospholipase A2Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome-Reference-Cited by-同舟云学术

Secretory Phospholipase A2Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome

Published:2006-01 Issue:2 Volume:30 Page:165-170
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Ballas Samir K.,Files Beatrice,Luchtman-Jones Lori,Benjamin Lennette,Swerdlow Paul,Hilliard Lee,Coates Thomas,Abboud Miguel,Wojtowicz-Praga Slawomir,Kuypers Frans A.,Michael Grindel J.

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,Genetics (clinical),Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/03630260600642260

Reference23 articles.

1. Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death

2. Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

3. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia

4. Acute chest syndrome and sickle cell disease

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secretory Phospholipase A2 as a Promising Biomarker for Predicting Acute Chest Syndrome in Children With Sickle Cell Disease: A Systematic Review and Meta-Analysis;Cureus;2024-09-10

2. Acute Chest Syndrome in Sickle Cell Disease;Transfusion Medicine Reviews;2023-07

3. Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers;Hematology/Oncology Clinics of North America;2022-12

4. Hyperinflammation, apoptosis, and organ damage;Experimental Biology and Medicine;2022-04-27

5. Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management;Expert Review of Hematology;2022-02-01